GOVIND SETH: Open Payments
NPI 1154775500 · DUNDALK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,695 in 78 payments from 24 companies in 2025. Trend: 2023 $721 · 2024 $744 · 2025 $1,695
Food & beverage: $1,695
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $214 |
| Novo Nordisk Inc | 11 | $212 |
| PFIZER INC. | 6 | $145 |
| AstraZeneca Pharmaceuticals LP | 6 | $140 |
| Indivior Inc. | 4 | $120 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Lilly USA, LLC | 4 | $97 |
| Orexo US, Inc. | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
Products named: HETLIOZ, NURTEC ODT, SUBLOCADE, BREZTRI, Ozempic, XIFAXAN, MOUNJARO, Zubsolv.
Industry payments across MD — which companies pay providers there.
